Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 24

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

643

HTML

3763

Tables (1-2)

235

Sum=4641

Jun 28, 2012 (publication date) through Dec 2, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jun 28, 2012; 18(24): 3167-3172
Published online Jun 28, 2012. doi: 10.3748/wjg.v18.i24.3167

Table 2 Pharmacoeconomic indices of mucoprotective drugs for outpatients in 2011

Drug name	Total dose (g)	DDD (g)	DDDs	Overall expenditure (CNY)	Daily expenditure (CNY)
Gefarnate	14 252	0.15	95 013	312 000	3.3
Hydrotalcite chewable tablet	282 842	3	94 280	557 000	7.4
Teprenone	11 345	0.15	75 633	380 000	5.0
Sucralfate oral suspension	459 648	8	57 456	444 000	7.7
Marzulene-S	89 880	2	44 940	250 000	5.6
Rebamipide	11 195	0.3	37 316	214 000	5.8
Sucralfate chewable tablet	13 950	4	3488	3600	1.0

MPs: Mucoprotective drugs; DDD: Defined daily dose; CNY: China Yuan.

Citation: Zhu LL, Xu LC, Chen Y, Zhou Q, Zeng S. Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications. World J Gastroenterol 2012; 18(24): 3167-3172
URL: https://www.wjgnet.com/1007-9327/full/v18/i24/3167.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i24.3167